Drugs / Hemp-derived cannabinoids
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT07393672 Comparator | Feb → Nov 2026 expected | premature menopause | Washington State University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hemp-derived cannabinoids | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07393672 ↗ |
| Route | Oral | “orally ingesting the morning and evening doses” NCT07393672 ↗ |